Broad range of off-patent oral and injectable formulations including metformin, sulfonylureas, and incretin mimetics for diabetes control. Generic manufacturers supply to bulk purchasers like hospital groups, pharmacy benefit managers, and international distributors for cost-effective diabetes treatment in diverse healthcare systems.